Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity

Launched by ASSIUT UNIVERSITY · Dec 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a protein called Follistatin-Like Protein 1 (FSTL-1) to see how it relates to Behçet's disease, a condition that causes inflammation in various parts of the body. Researchers want to understand if measuring levels of this protein can help identify how active the disease is and potentially assist in diagnosing it. The trial aims to gather more information about Behçet's disease, which is still not fully understood, by focusing on how this protein behaves in patients.

To participate in this study, you need to be an adult diagnosed with Behçet's disease according to specific international guidelines. However, individuals with other autoimmune diseases, like rheumatoid arthritis or lupus, will not be included. If you join the trial, you'll have the chance to contribute to important research that may help improve understanding and treatment of Behçet's disease. The study is currently recruiting participants of all genders between the ages of 65 and 74.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult BD patients who fulfilling the criteria for the diagnosis by International Team for the Revision of the International Criteria for Bechet's Disease
• Exclusion Criteria:
• • Individuals with other autoimmune diseases (rheumatoid arthritis dermatomyositis, scleroderma, mixed connective tissue disease).